4057 State Route 3, Star Lake, NY 13690 Phone: (315) 848-3784 | Fax: (315) 848-5129 Mon-Fri 9:00am - 5:00pm | Sat-Sun Closed
Adirondack Pharmacy offers immunizations by appointment.
Please call us to schedule your appointment or if you need us to help you decide which vaccinations you need.
(315) 848-3784 

NEW! Access your prescriptions online. Click
Adirondack Pharmacy Logo

Manténgase sano!

An Infectious Combo Triples Risk Of MS, Study Says
  • Posted April 15, 2026

An Infectious Combo Triples Risk Of MS, Study Says

WEDNESDAY, April 15, 2026 (HealthDay News) — An Epstein-Barr virus infection that results in a case of mono appears to triple the risk of one day developing multiple sclerosis, a new study says.

Epstein-Barr, a herpes virus, is the most common cause of infectious mononucleosis, researchers said.

Now, it seems that one-two punch might increase the risk of the degenerative brain disease MS, according to findings recently published in Neurology Open Access.

“These results highlight the need for further research into ways to prevent infection with the Epstein-Barr virus,” said lead researcher Jennifer St. Sauver, an epidemiologist at the Mayo Clinic in Rochester, Minnesota.

“Preventing these infections could reduce the overall burden of MS,” St. Sauver said in a news release. “While MS is relatively rare, it carries the risks of significant disability and high treatment costs, and it usually develops when people are in their prime years of working and raising families.”

For the study, researchers analyzed more than two decades of health care records to find people who had a positive test for Epstein-Barr virus and infectious mononucleosis, identifying 4,721 patients.

The team compared each person with three other people the same age and sex who never had mono, to see if there were any differences in rates of MS.

During an average eight years of follow-up, eight people who’d had mono developed MS, or about 0.17%.

By comparison, 10 people who never had mono developed MS, but their larger group meant that they represented only 0.07%.

All told, people who’d had mono were a little more than three times as likely to develop MS, results show.

“Mononucleosis is a relatively uncommon illness, but developing strategies to prevent infection with the virus that causes this disease could help us to lower the number of MS cases in the future,” St. Sauver said.

These results are in line with other studies that have linked Epstein-Barr virus or mononucleosis to MS, researchers said.

Researchers could not say why mono caused by Epstein-Barr might raise MS risk.

They also noted that their study doesn’t prove a cause-and-effect link between mono and MS, but only shows an association.

More information

The U.S. Centers for Disease Control and Prevention has more about mononucleosis.

SOURCE: American Academy of Neurology, news release, April 1, 2026

HealthDay
El servicio de noticias de salud es un servicio para los usuarios de la página web de Adirondack Pharmacy gracias a HealthDay. Adirondack Pharmacy ni sus empleados, agentes, o contratistas, revisan, controlan, o toman responsabilidad por el contenido de los artículos. Por favor busque consejo médico directamente de un farmacéutico o de su médico principal.
Derechos de autor © 2026 HealthDay Reservados todos los derechos.

Compartir

Etiquetas